Barcelona, Spain

Núrla Valls Vidal

This inventor holds 1 USPTO granted patent. Top assignee: Oryzon Genomics S.a.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Núrla Valls Vidal. Retrieved from https://idiyas.com/inventor/núrla-valls-vidal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Núrla Valls Vidal: Innovator in Cyclopropylamine Compounds

Introduction

Núrla Valls Vidal is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on cyclopropylamine compounds.

Latest Patents

Núrla holds a patent for "Cyclopropylamine inhibitors of oxidases." This invention relates to cyclopropylamine compounds, specifically the compounds of Formula (I) as described and defined in his patent. These compounds have potential therapeutic applications, including the treatment or prevention of cancer.

Career Highlights

Núrla Valls Vidal is associated with Oryzon Genomics S.A., a company focused on developing innovative therapies. His work has positioned him as a key figure in the research and development of new medicinal compounds.

Collaborations

He has collaborated with notable colleagues, including Julio Cesar Castro-Palomino Laria and Matthew Colin Thor Fyfe. Their combined expertise contributes to the advancement of research in their field.

Conclusion

Núrla Valls Vidal's contributions to the development of cyclopropylamine compounds highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for new therapeutic options in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…